What gives execs comfort & concern about Medicaid redeterminations

The latest stories trending on MedCity News.

Editor's Pick

Top Story What Gives 3 Execs Comfort and Concern About Medicaid Redeterminations During a panel at the AHIP Medicare, Medicaid, Duals and Commercial Markets Forum, three executives were asked what gives them comfort about the return to Medicaid redeterminations, as well as what worries them. One CMS official said she's pleased that states are ramping up communication efforts for Medicaid enrollees, but is concerned about the "insurmountable task" ahead. Sponsored Content Interoperability and Price Transparency in the 21st Century Cures Act: A Payer's Perspective Presented by Intelligent Medical Objects and MedCity News Join us on April 11th  for this webinar sponsored by Intelligent Medical Objects, which will explore how payers are meeting the needs of the 2016 21st Century Cures Act when it comes to providing unfettered access to structured medical data for members. Register Today and Watch For Free!

Featured News

How the EU's New Data Laws Could Affect American Health Tech Companies In the EU, there is a widespread distrust of American tech companies, according to a recent conference presentation by an international healthcare lawyer. Because of this, the EU has established a number of new laws protecting its citizens' data privacy and creating frameworks for the secure exchange of information — laws that American health tech companies will have to comply with if they do business in the EU. Too Many Dashboards, Not Enough Insight: How Companies Can Build Remote Patient Monitoring Tech To build remote patient monitoring technology for ready adoption, repetitive data streams must be avoided. To be successful in clinical adoption, we offer technology companies the following three recommendations. FDA Approval Makes Pharming Drug First for Rare Inherited Immune Disease Pharming Group drug Joenja was awarded FDA approval for treating a primary immunodeficiency called activated phosphoinositide 3-kinase delta syndrome, or APDS. It's the first treatment for the rare disorder. Court Ruling Leaves 340B Providers Waiting for Clarity About the Use of Contract Pharmacies In recent years, manufacturers have restricted access to 340B pricing for drugs dispensed through contract pharmacies. The federal government has advised manufacturers that such restrictions are unlawful, and manufactures have challenged government enforcement actions in federal court.

Resources

10 Ways to Decode Silicon Valley Bank Collapse Shared with you in the form of 10 questions to encourage probing further into what happened and how it could have been prevented. Download Now

MedCity News • 611 Broadway • New York, NY unsubscribe